Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2025-12-24 @ 4:08 PM
NCT ID:
NCT05531266
Eligibility Criteria:
Inclusion Criteria:
* Patient who has undergone an allogeneic haematopoietic stem cell transplantation (HSCT) and developed acute graft versus host disease (aGVHD)
* Eastern Cooperative Oncology Group (ECOG) Performance status 0-2
* serum creatinine less than twice the upper limit of normal or creatinine clearance greater 50 ml/min within 28 days.
* Patients had recovered from previous treatments
* Signing written informed consent and agreeing with taking designated umbilical cord blood
Exclusion Criteria:
* Patients had severe allergy history
* Patients with unstable angina or whose cardiac function grading III-IV.
* Patients with chronic respiratory disease requiring continuous oxygen supplement
* Patients with active hepatitis B or active hepatitis C or AIDS infection
* Patients with Uncontrolled viral or bacterial infections
* Patients with severe psychiatric or physical illness that would limit compliance with study requirements
* Patients who received any other investigational study or treatment within 30 days
* Secondary malignancy
* Allergic to blood products
* Other causes which are not suitable for the trial in investigator's consideration
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05531266
Study Brief:
Protocol Section:
NCT05531266